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Peripheral nervous system (PNS) neurons survive and regenerate after nerve injury,
whereas central nervous system (CNS) neurons lack the capacity to do so. The inability
of the CNS to regenerate presumably results from a lack of intrinsic growth activity and
a permissive environment. To achieve CNS regeneration, we can learn from successful
nerve regeneration in the PNS. Neurons in the PNS elicit dynamic changes in gene
expression in response to permissive environmental cues following nerve injury. To
switch gene expression on and off in injured neurons, transcription factors and their
networks should be carefully orchestrated according to the regeneration program. This
is the so-called “intrinsic power of axonal growth.” There is an increasing repertoire of
candidate transcription factors induced by nerve injury. Some of them potentiate the
survival and axonal regeneration of damaged neurons in vivo; however, our knowledge of
transcriptional events in injured neurons is still limited. How do these transcription factors
communicate with each other? How does the transcriptional machinery regulate the wide
variety of regeneration-associated genes (RAGs) in the properly coordinated manner? In
this review, we describe our current understanding of the injury-inducible transcriptional
factors that enhance the intrinsic growth capacity, and propose a potential role for
specificity protein 1 (Sp1), which provides a platform to recruit injury-inducible transcription
factors, in simultaneous gene regulation. Finally, we discuss an additional mechanism
that is involved in epigenetic modifications in damaged neurons. A comprehensive
understanding of the nuclear events in injured neurons will provide clues to clinical
interventions for successful nerve regeneration.
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INTRODUCTION
Unlike neurons of the peripheral nervous system (PNS), the cen-
tral nervous system (CNS) neurons are unable to survive and
regenerate after nerve injury (Filbin, 2003; Harel and Strittmatter,
2006). This serious problem has led tomany studies being focused
on how to drive axon elongation in the CNS. However, the molec-
ular mechanisms underlying successful nerve regeneration in the
PNS remains to be elucidated. It will be difficult to overcome the
problem in the CNS without a basic understanding of the exact
mechanisms underlying successful nerve regeneration. From this
respect, an understanding of nerve regeneration in the PNS is of
both basic and potential clinical interest.
There are two major determinants of successful nerve regen-
eration, intrinsic growth ability and an extrinsic permissive
environment (Chen et al., 2007; Raivich and Makwana, 2007).
Injured neurons switch the expression of regeneration-associated
genes (RAGs) on and off according to the regeneration program
(Raivich and Makwana, 2007; Sun and He, 2010). We refer to this
process as “intrinsic growth ability.” The activation of intrinsic
growth capacity depends on the existence of a local permissive
environment, which consists of the molecular network organized
by Schwann cells and macrophages at the injury site, and by
astrocytes and microglia around the cell bodies (Figure 1;
Leon et al., 2000; Moran and Graeber, 2004; Raivich, 2005). This
environment produces neurotrophic factors such as nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF), glial
cell line-derived factor (GDNF), and neurotrophin-3 (NT-3)
(Lindholm et al., 1987; Yan et al., 1992; Funakoshi et al., 1993;
Li et al., 1994; Naveilhan et al., 1997); cytokines such as leukemia
inhibitory factor (LIF), ciliary neurotrophic factor (CNTF),
interleukin-6 (IL-6), and chemokines (Sendtner et al., 1990;
Banner and Patterson, 1994; Curtis et al., 1994; Murphy et al.,
1995; Cafferty et al., 2004; Cao et al., 2006); chemoattrac-
tants like chemokine (Namikawa et al., 2006; Yin et al., 2006;
Gamo et al., 2008); neuropeptides like calcitonin gene-related
peptide (CGRP), galanin, and vasoactive intestinal peptide
(VIP) (Shadiack et al., 2001); cell adhesion molecules like CD44,
integrin, and L1 (Nieke and Schachner, 1985; Jones et al., 1997;
Kloss et al., 1999; Werner et al., 2000); and numerous extra-
cellular matrix (ECM) molecules (Araki and Milbrandt, 2000;
Murakami et al., 2006). On the contrary, in the non-permissive
environment in the CNS, astrocytes form a physical barrier
to growth and oligodendrocytes generate molecules that are
highly inhibitory to axon growth (Silver and Miller, 2004;
Benowitz and Yin, 2008; Shen et al., 2009; Lee et al., 2010). In
the PNS, nerve injury signals from the permissive environment
are transduced via cell surface receptors of the cell body and
via retrograde axonal transport (Hanz et al., 2003; Cavalli et al.,
2005; Yudin et al., 2008), and then activate intracellular cascades
like the mitogen-activated protein kinase (MAPK) pathway
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FIGURE 1 | Peripheral nerve injury elicits a dynamic change in the
transcription of regeneration-associated genes (RAGs) to enhance
intrinsic growth capacity in neurons. The transcription factors involved in
nerve regeneration are expressed at low-level in normal neurons. RAGs are
expressed at low-level or switched off. Upon axotomy, microglial cells and
subsequent astrocytes surround the cell body of injured neuron. Synaptic
terminals are detached from the cell body. At the injury site, Schwann cells
undergo dedifferentiation and proliferation, and Schwann cells and
macrophages rapidly remove myelin debris. The local permissive
environment provides the injury signals via cell surface receptors of the cell
body and via retrograde axonal transport from growth cone. The signals
induce the expression of numerous transcription factors, modify them at the
post-translational level and lead to form various types of transcriptional
complex, to promote the RAGs expression (See main text for details).
and the phosphoinositide 3-kinase (PI3K) pathway in injured
neurons (Kiryu et al., 1995a; Liu et al., 1997; Namikawa et al.,
2000; Markus et al., 2002; Zhou and Snider, 2005; Park et al.,
2008; Hammarlund et al., 2009). Ultimately, the signals are
integrated into specific regulators of the nuclear transcrip-
tion factors that induce the expression of large ensembles
of distinct genes sequentially and under tight control. The
repertoire of transcription factors that are induced by nerve
injury is increasing. They include c-Jun, sox11, CREB, Smad1,
ATF3, AKRD1, NFIL3, p53, STAT3, C/EBPβ, and several KLF
family members (Herdegen et al., 1997; Tsujino et al., 2000;
Schweizer et al., 2002; Nakagomi et al., 2003; Gao et al., 2004;
Raivich et al., 2004; Kiryu-Seo et al., 2005; Nadeau et al., 2005;
Qiu et al., 2005; Jankowski et al., 2006; Okuyama et al., 2007;
Moore et al., 2009; Zou et al., 2009). Cox et al. have reported
that CREB is locally synthesized in growth cone and retrogradely
transported to the cell body (Cox et al., 2008). Axonally derived
transcription factors may be involved in a specific response to the
injury site.
Recent large-scale screening approaches using a combina-
tion of microarrays with phosphoproteomics have identified
39 injury-inducible transcription factors (Michaelevski et al.,
2010), while the comparative transcriptome microarray analy-
sis of peripheral versus central nerve injured models of dorsal
root ganglion (DRG) neurons found 30 candidate transcrip-
tion factors (Stam et al., 2007). These injury-inducible tran-
scription factors are presumed to control hundreds of tran-
scriptional targets. It has been established that the 5′-flanking
sequences of some RAGs such as an important regulator of
growth cone motility, GAP43 (Kobayashi et al., 1994), interme-
diate filament, peripherin (Terao et al., 2000), and cytoskeletal
protein, α-tubulin (Tetzlaff et al., 1988), have injury-responsive
characteristics (Belecky-Adams et al., 1993; Gloster et al., 1994;
Vanselow et al., 1994; Uveges et al., 2002). Recent genome-wide
screening of gene promoters identified multiple potential target
genes (MacGillavry et al., 2011). However, our knowledge of the
targets is limited.
A principal goal in the field has been to identify the mas-
ter regulators that coordinate the regenerative program, and to
understand the global gene regulation processes that drive intrin-
sic growth ability. It is required to know how such a large number
of transcription factors interplay with each other to regulate RAGs
synchronously, and how global and dynamic changes in gene
expressions are controlled. In this review, we describe the current
understanding of the transcription factors associated with nerve
regeneration and highlight our finding of the specificity pro-
tein 1 (Sp1)-dependent transcriptional machinery as a result of
its interactions with injury-inducible transcription factors. This
finding has raised several unanswered questions to be addressed
in the future. Finally, we discuss the possible involvement of epi-
genetic regulation in nerve regeneration, including chromatin
remodeling and DNA methylation.
TRANSCRIPTION FACTORS INVOLVED IN NERVE
REGENERATION
The physiological relevance of both injury-inducible transcrip-
tion factors and their potential targets awaits in vivo study. Recent
exciting work using knockout and transgenic mice is uncov-
ering their relevance, as shown in Table 1. C/EBPβ knockout
mice showed reduced expression of RAGs such as α-tubulin
and GAP-43 after facial nerve injury (Nadeau et al., 2005).
Deletion of the tumor suppressor p53 rescued the motor neu-
ron death after hypoglossal nerve injury by preventing expres-
sion of the proapoptotic gene Noxa (Kiryu-Seo et al., 2005).
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Table 1 | The phenotypes of injured neurons in genetically modified mice.
Gene Modification Injury model Effects References
Survival Regeneration Gene expression∗1
c-Jun KO facial n. ↑ ↓ ↓ Raivich et al. (2004)
ATF3 Tg sciatic n. n.d. ↑ ↑∗2 Seijffers et al. (2006)
STAT3 KO facial n. ↓ n.d.∗3 ↓ Schweizer et al. (2002)
C/EBPβ KO facial n. n.d. n.d. ↓ Nadeau et al. (2005)
p53 KO hypoglossal n. ↑ ↑ ↓ Kiryu-Seo et al. (2005)
facial n. Di Giovanni et al. (2006)
KLF4 KO optic n. ± ↑ n.d. Moore et al. (2009)
KO, gene deletion; Tg, overexpression; n., nerve; ↑, increase; ↓, decrease; n.d., not determined; ±, no effect.
∗1Gene expression denotes that genetically modified mice alter the expression of the survival/regeneration-associated genes in the injured neurons, compared with
wild type mice.
∗2Exceptionally, ATF3 Tg mouse shows an increase in the RAGs expression in the non-injured neurons.
∗3The improved axonal regeneration is observed in SOCS3 KO mouse.
However, Giovanni et al. demonstrated that the role of p53 is
predominantly one of axonal regeneration rather than cell sur-
vival after facial nerve axotomy (Di Giovanni et al., 2006). It is
possible that p53 has a dual role, because p53 is a multifunc-
tional and stress-sensitive protein that initiates numerous tran-
scriptional cascades in response to nerve injury. The absence of
Krüppel-like factor-4 (KLF4) in retinal ganglion cells modestly
enhanced axonal regeneration after optic nerve injury, suggest-
ing that KLF4 is a negative regulator of intrinsic growth ability
(Moore et al., 2009). Gao et al. have shown that the injection of
the adenovirus containing constitutively active CREB into the
DRG enhanced nerve regeneration, although these authors did
not use a genetically modified mouse (Gao et al., 2004). All of
these studies have provided valuable in vivo information about
the gene regulation events that elevate intrinsic growth abil-
ity. Furthermore, the prominent effects of c-Jun, ATF3, and
STAT3 on nerve regeneration have been particularly well exam-
ined. Here, we summarize the current understanding of the roles
of these three injury-inducible transcription factors in nerve
regeneration.
C-JUN
c-Jun is a major component of the activator protein-1 (AP-1)
family of transcription factors and forms homo- and het-
erodimers together with Jun family proteins (c-Jun, JunB,
and JunD) and Fos proteins (c-fos, FosB, Fra-1, and Fra-2)
(Herdegen and Leah, 1998). Many Jun family proteins depend
on the activation of N-terminal kinases (JNKs) and are involved
in a large number of cellular functions. N-terminal phospho-
rylated c-Jun is rapidly accumulated in the nucleus where it
promotes neuronal death (Herdegen et al., 1997). This phe-
nomenon is observed during embryonic development as well
as in a variety of nerve injury models (Herdegen et al., 1997;
Raivich et al., 2004; Lindwall and Kanje, 2005). Thus, overexpres-
sion of c-Jun leads to cell death by inducing propapoptotic genes
such as Bim, whereas c-Jun suppression or dominant-negative
c-Jun expression prevents neuronal death (Ham et al., 1995;
Whitfield et al., 2001; Palmada et al., 2002). Peripheral nerve
injury induces c-Jun expression, suggesting its involvement in
nerve regeneration (Raivich et al., 2004). However, the situation
is not so simple. Neuronal death is sometimes induced even
by peripheral nerve axotomy. This phenomenon is more aug-
mented in mice than in rats (Kiryu-Seo et al., 2005, 2006). Using
this feature, Raivich et al. demonstrated that c-Jun seems to
have a dual role like p53. They established mice with nestin-
Cre-mediated neuronal deletion of c-Jun. The c-Jun-negative
motor neurons blocked neuronal death after facial axotomy,
although they still showed severe neuronal atrophy. Despite show-
ing inhibition of neuronal death, the mice showed strongly
diminished speed of target innervation regeneration after nerve
injury. Furthermore, they showed reduced expression of sev-
eral RAGs including cell adhesion molecules such as integrin
α7β1 and CD44 (Jones et al., 1997; Werner et al., 2000) and neu-
ropeptides such as galanin (Shadiack et al., 2001). This finding
reinforces the notion that c-Jun has an important role in turning
on the regeneration program after injury. This does not exclude
the possibility that a lack of c-Jun affects non-neuronal cells
in these mice in addition to neurons, because the nestin-Cre-
mediated deletion of c-Jun also occurs in glial cells. c-Jun can
drive Schwann cell dedifferentiation and is upregulated in non-
neuronal cells like Schwann cells after axotomy. In line with this
fact, mice with conditional inactivation of c-Jun in Schwann cells
showed strikingly delayed myelin loss after sciatic nerve injury
(Parkinson et al., 2008). Because rapid removal of myelin enables
axon regeneration in the PNS (Vargas and Barres, 2007), these
mice would be expected to have compromised functional recov-
ery after nerve injury. Further study is required to elucidate these
points.
ATF3
Activating transcription factor 3 (ATF3) is a stress-inducible
transcription factor, which binds to the ATF/CRE site
(Hai and Hartman, 2001). ATF3 is not normally found in
neuronal cells but is highly expressed in response to nerve injury.
Thus, ATF3 is known as an injury marker in the nervous system
(Tsujino et al., 2000; Nakagomi et al., 2003; Ohba et al., 2003).
The role of ATF3 diverges according to the cellular context and/or
the components of the ATF3-containing complex. ATF3 forms
Frontiers in Molecular Neuroscience www.frontiersin.org December 2011 | Volume 4 | Article 53 | 3
Kiryu-Seo and Kiyama Nuclear events guiding nerve regeneration
homo- and heterodimers to function as both a repressor and
activator of genes (Hai and Hartman, 2001).
ATF3 seems to be a major determinant of the intrinsic growth
state of neurons. ATF3 expression is correlated with the sur-
vival and activation of intrinsic growth ability in CNS neurons
(Ohba et al., 2003; Campbell et al., 2005; Zhang et al., 2011b).
Overexpression of ATF3 in cultured superior cervical ganglion
(SCG) neurons protects against cell death after NGFwithdrawal, a
popular apoptotic stimulus, while it enhances neurite outgrowth
in both SCG neurons and DRG neurons (Nakagomi et al., 2003;
Seijffers et al., 2006). Mice overexpressing ATF3 under the con-
trol of the neuron-specific Thy1.2 promoter revealed enhanced
neurite elongation in vitro and in vivo after sciatic nerve injury
(Seijffers et al., 2006). ATF3 is also up-regulated as an adaptive
response in cultured demyelinated DRG neurons and increases
the speed of axonal mitochondrial transport, probably to main-
tain axonal homeostasis (Kiryu-Seo et al., 2010). To achieve these
roles, ATF3 has been believed to dimerize with c-Jun in a context-
specific manner. The concurrent expression of c-Jun with ATF3
is frequently observed in damaged neurons after nerve injuries,
including peripheral axotomy andMiddle Cerebral Artery (MCA)
occlusion (Nakagomi et al., 2003; Ohba et al., 2003). There is
also in vitro evidence to show an interaction between ATF3 and
c-Jun (Chen et al., 1996; Nakagomi et al., 2003). However, an
interaction between ATF3 and c-Jun has not been reported in
vivo to date. It is likely that some previously unidentified sig-
naling pathway or associated proteins, which are activated by
nerve injury, are involved in facilitating the dimerization of ATF3
and c-Jun.
Information about the target genes of ATF3 is still lim-
ited, although ATF3 can bind to an atypical ATF/CRE site in
the Heat shock protein (Hsp) 27 promoter (Benn et al., 2002;
Nakagomi et al., 2003). The aforementioned ATF3 transgenic
mouse altered the expression of a set of RAGs in non-injured
DRG neurons (Seijffers et al., 2006). They include c-Jun, Hsp27
which prevents neuronal death (Lewis et al., 1999), Small proline-
rich repeat protein (SPRR) 1A which promotes axonal out-
growth (Bonilla et al., 2002), and CAP23 which is function-
ally related to GAP43 (Bomze et al., 2001). These genes might
be candidate targets of ATF3. If a potential counterpart like
c-Jun is activated at the same time, much greater induction
of much more RAGs may be observed in non-injured DRG
neurons.
To clarify the importance of ATF3 in injured neurons, ATF3
knockout mouse will be a useful tool (Hartman et al., 2004). To
date, ATF3-deficient mouse lines have revealed no obvious abnor-
malities in neurite elongation or survival after nerve injury. This
is probably because the mouse is not a complete null mutant,
but still expresses the DNA-binding domain and leucine zipper
domain of the protein, resulting in abundant expression of a small
fragment protein and mRNA after nerve injury (Seijffers et al.,
2007) and our observations.
STAT3
Signal transducer and activator of transcription 3 (STAT3) is
activated in response to growth factors, cytokines, and hor-
mones that are known to play protective role after nerve injury
(Dziennis and Alkayed, 2008). Binding of these growth factors
or cytokines to their cognate receptors, including the common
receptor subunit gp130, activates Janus kinase (JAK), which phos-
phorylates tyrosine residues on the cytoplasmic portion of the
receptor complex, and then phosphorylates STAT3. In general,
axotomy increases the expression and phosphorylation of STAT3
(Schwaiger et al., 2000; Qiu et al., 2005). To examine the role of
STAT3 in vivo, Schweizer et al. used mice with neuron-specific
ablation of STAT3 created by Cre recombinase expression under
the control of the neurofilament light chain (NF-L) promoter
(Schweizer et al., 2002). The study indicated that STAT3 con-
tributes to the survival of motor neurons after facial nerve lesions
through activation of Reg2 and Bcl-XL (Gonzalez-Garcia et al.,
1995; Livesey et al., 1997), which promote neuronal survival.
Schweizer et al. did not investigate axonal regeneration using
these mice. However, other studies implicated an effect of
STAT3 on nerve regeneration using the peripheral conditioning
injury paradigm and optic nerve injury model. The condition-
ing lesion paradigm is a widely accepted model in which ele-
vated intrinsic growth ability caused by prior peripheral nerve
axotomy facilitates subsequently lesioned dorsal column axons
to regenerate over a short distance (Richardson and Issa, 1984;
Neumann and Woolf, 1999). Qiu et al. demonstrated that STAT3
activation is necessary for increased growth ability of DRG neu-
rons and improved axonal regeneration in the spinal cord after
conditioning injury (Qiu et al., 2005). Furthermore, the dele-
tion of suppressor of cytokine signaling 3 (SOCS3), which is a
negative regulator of the JAK/STAT3 pathway, promotes axonal
regeneration after optic nerve injury (Smith et al., 2009). Thus, a
considerable body of evidence points to an involvement of STAT3
in nerve regeneration.
Apart from the well-understood job of STAT proteins in trans-
mitting transcriptional signals from the cell surface to the nucleus,
a new finding reveals that mitochondrial localization of STAT3
contributes to oxidative phosphorylation, leading to regulation
of respiration (Gough et al., 2009). Furthermore, other studies
claim that unphosphorylated STAT3 can be also imported into the
nucleus independent of phosphorylation and, once there, regulate
gene transcription by binding to other nuclear proteins (Liu et al.,
2005; Yang et al., 2005). Although the physiological relevance of
these newly discovered functions of STAT3 remains to be estab-
lished, these findings expand our classical understanding of gene
regulation by STAT3.
COOPERATIVE TRANSCRIPTIONAL REGULATION BY
INJURY-INDUCIBLE TRANSCRIPTION FACTORS
As mentioned above, numerous candidate injury-inducible tran-
scription factors have been identified to date. How do those
injury-inducible transcription factors communicate with each
other and/or participate in the complex molecular machine? How
do they access distinct RAGs with common or different injury-
responsible DNA elements? We have assumed that one of the best
ways to answer the questions is via the promoter analysis of a
representative nerve RAG, which gives us clues to resolve these
mysteries. From this point of view, damage-induced neuronal
endopeptidase (DINE) is considered to be an ideal representative
gene to provide further information about how injury-inducible
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transcription factors cooperate with each other during nerve
regeneration.
NERVE REGENERATION-ASSOCIATED GENE DINE
Previous large-scale screening studies from our laboratory and
others have identified numerous potential RAGs (Kiryu et al.,
1995b; Tanabe et al., 1999; Bonilla et al., 2002; Costigan et al.,
2002; Tanabe et al., 2003). The aim of our studies has been
to understand the molecular basis underlying nerve regener-
ation. In addition, another important goal has been to find
pan-nerve injury-inducible genes. These aims are based on the
idea that there must be common injury-responsive transcrip-
tional machinery in both the PNS and CNS, which triggers
RAG expression and will be a potential key to enabling robust
CNS regeneration to proceed in the future. In a search for
RAGs, we identified DINE (Kiryu-Seo et al., 2000), which another
group isolated independently as XCE later registered as endothe-
lin converting enzyme-like 1 (ECEL-1); (Valdenaire et al., 1999).
The most intriguing property of DINE is its extreme transcrip-
tional response against various kinds of nerve injuries, both
in the PNS and CNS, including motor, sensory and sympa-
thetic nerve injuries, brain and spinal cord trauma, and cerebral
ischemia (Kiryu-Seo et al., 2000; Boeshore et al., 2004), which led
to its name (Kiryu-Seo et al., 2000). The enhanced expression of
DINE is strikingly restricted to neuronal cells, and not seen in
glial cells. DINE mRNA induction is always accompanied by the
induction of ATF3, in various injury models (Nakagomi et al.,
2003; Ohba et al., 2004). DINE mRNA is significantly induced
by LIF treatment and NGF withdrawal both in vitro and in vivo,
suggesting that c-Jun, ATF-3, and STAT3 are candidate tran-
scription factors downstream of LIF-gp130 signaling and JNK
signaling for transactivation of DINE gene (Kato et al., 2002;
Kiryu-Seo and Kiyama, 2004).
At the protein level, DINE functions as a neuron-specific
membrane-bound metalloprotease. It shares homology with
neprilysin (NEP) and endothelin converting enzyme (ECE),
which degrade or process neuropeptides such as amyloid β and
endothelin, which play important roles in Alzheimer pathol-
ogy and migration from the neural crest, respectively (Xu et al.,
1994; Iwata et al., 2000). DINE is supposed to have a critical
role in injured neurons, although its substrate remains unknown
(Shirotani et al., 2001). DINE-deficient mice die immediately
after birth due to respiratory failure (Schweizer et al., 1999;
Nagata et al., 2010). This is caused by the failure of distal axonal
arborization into muscle, resulting in poor formation of neuro-
muscular junctions (NMJ) (Nagata et al., 2010). Because DINE
deficiency leads to abnormal axon behavior during development,
DINE is expected to function during nerve regeneration as well
(Nagata et al., 2006, 2010). Thus, DINE is considered to be a fas-
cinating target gene with which to examine the transcriptional
mechanisms involved in the response to nerve injury.
SP1-MEDIATED TRANSCRIPTIONAL COMPLEX
Using the DINE promoter, we identified activation of the Sp1-
mediated transcriptional machinery in response to nerve injury
(Kiryu-Seo et al., 2008). Here, we describe this machinery and
propose a potential explanation for how a cohort of nerve
injury-induced transcription factors participates in the dynamic
alteration of gene expression during nerve regeneration.
The 5′-flanking region of the DINE gene is thought to con-
tain the injury-responsive element. DINE promoter activity was
enhanced in response to LIF treatment and NGF withdrawal in
cultured DRGs, mimicking the endogenous response of DINE
mRNA (Kato et al., 2002). Co-expression of ATF3, c-Jun, and
STAT3 increased DINE promoter activity by a small amount.
This is because the efficient dimerization of c-Jun and ATF3
does not occur in this context. It is unclear what makes c-Jun
and ATF3 dimerize, although the heterodimer is believed to pro-
mote axonal regeneration (Nakagomi et al., 2003). There may
exist some unidentified signal that makes the heterodimer sta-
ble in injured neurons. Thus, we used a forced heterodimer of
ATF3 and c-Jun in our experiment. The forced heterodimer up-
regulated DINE promoter activity tremendously, with a further
increase observed in the presence of STAT3, suggesting that these
injury-inducible transcription factors contribute to the regulation
of the DINE promoter. Unexpectedly, c-Jun, ATF3, and STAT3
did not directly bind to a specific element within the DINE
promoter. Instead, Sp1 directly bound to the GC-rich region
located in the region proximal to the transcription start site of the
DINE promoter, and could function as a scaffolding protein to
recruit c-Jun, ATF3, and STAT3 to elicit their functional synergy
(Figure 2; Kiryu-Seo et al., 2008). Of the complex, ATF3, which
makes subsequent dimerization with c-Jun, may be the most crit-
ical, because ATF3 is specifically expressed after nerve injury. The
A
B
FIGURE 2 | Possible mechanism of the Sp1-mediated transcriptional
machinery to induce the regeneration-associated gene DINE in
response to nerve injury. (A) Transcriptional regulation of DINE before and
after nerve injury. In the normal conditions, Sp1 and the unknown
transcriptional complex express DINE at the low-level. Following nerve
injury, injury-inducible transcription factor ATF3 form a heterodimer with
cJun and Sp1 provides a platform to recruit ATF3, c-Jun, and Stat3. (B) The
activity of Sp1 can be regulated by post-translational modifications including
phosphorylation, acetylation, ubiquitination. Additional transcription factors
and chromatin modifiers may participate in the Sp1-mediated transcriptional
complex shown in (A).
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findings of an in vivo study using chromatin immunoprecipi-
tation (ChIP) assay supported the existence of such a complex
in injured hypoglossal neurons. We could not rule out the pos-
sibility that these transcription factors, like c-Jun, ATF3, and
STAT3, regulate the DINE gene by binding to individual bind-
ing sites separately in an unidentified enhancer region, and that a
combination of these proposed transcriptional mechanisms reg-
ulates the expression of DINE. However, consistent with our
finding, it has been reported that gene promoters without the
AP1 site or without the STAT3 binding site were activated by
c-Jun or STAT3 through an interaction with Sp1 (Kardassis et al.,
1999; Chen and Chang, 2000). Importantly, the mechanism by
which Sp1may provide c-Jun/ATF3/STAT3with a platformwould
be practical and effective when increased gene expression is
required in the event of a fatal emergency such as neuronal injury.
Many neuronal genes contain the Sp1 binding site (Ross et al.,
2002), suggesting that nerve injury-inducible transcription fac-
tors are capable of accessing many genes without specific
binding sites.
MULTIFUNCTIONAL TRANSCRIPTION FACTOR SP1
Sp1 is a general transcription factor that binds to GC-rich motifs
with high affinity. Sp1 was thought to serve mainly as a constitu-
tive activator of housekeeping genes in a classical view. Growing
evidence suggests that Sp1 is a multifunctional transcription
factor.
At the transcriptional level, Sp1 is not induced in injured neu-
rons, but is expressed constitutively. The regulation of Sp1 is
important at the protein level. The activity of Sp1 is regulated by
post-translational modifications, as well as by interaction part-
ners. Phosphorylation, acetylation, sumoylation, ubiquitination,
and glycosylation are among the post-translational modification
that can influence the transcriptional activity and stability of
Sp1 (Hung et al., 2006; Tan and Khachigian, 2009). The accessi-
bility of injury-inducible transcription factors may be determined
by the modification of Sp1, suggesting the possibility that dif-
ferent modifications of Sp1 recruit different injury-inducible
transcription factors. The activity of Sp1 is also regulated by inter-
actions or interplay with other transcription factors such as p53,
c-myc, Smad, AP-2, and E2F-1 (Wierstra, 2008). These additional
transcription factors may participate in the Sp1/c-Jun/ATF3/
STAT3 complex to yield maximum effects in injured neurons
(Figure 2).
The involvement of Sp1 is illuminated in the neurodegen-
erative disease Huntington disease (HD). Sp1 is induced and
acetylated under the conditions of oxidative stress observed in
HD neurons (Ryu et al., 2003b; Qiu et al., 2006). Sp1 induction
confers a resistance to oxidative stress-induced cell death through
transcriptional activation (Ryu et al., 2003a). In HD pathology,
mutant huntingtin (Htt) interacts with Sp1 and core components
of the transcriptional machinery, leading to disruption of tran-
scriptional activation of neuronal genes such as the dopamine D2
receptor (Dunah et al., 2002; Freiman and Tjian, 2002; Zhai et al.,
2005). Conversely, others have reported that a decrease in the
Sp1 level has a beneficial effect on HD pathology (Qiu et al.,
2006; Ravache et al., 2010). These results seem to be contradic-
tory. The reason for this may be attributable to the diverging
role of Sp1. Recently, Sleiman et al. demonstrated that a GC-
rich DNA-binding drug mithramycin (MTM), which competes
with Sp1 for its binding site, prevents neuronal death in the HD
model of Drosophila as well as in cultured cortical neurons under
conditions of oxidative stress. The protective role depends on
the selectivity of MTM, meaning that MTM selectively binds to
the GC-box of proapoptotic genes like myc but not that of anti-
apoptotic genes like p21 (Sleiman et al., 2011). The mechanism
of action remains unknown; however, this work suggests that Sp1
could be a target of therapeutic strategies.
Interestingly, Sp1 interacts with chromatin-modifying factors
such as p300, histone acetylases (HATs) and histone deacetylases
(HDACs) (Ryu et al., 2003a; Hung et al., 2006), while the Sp1
target sequence, the GC-box, can be a substrate for DNAmethyla-
tion. It is therefore, an attractive possibility that Sp1 is a target for
epigenetic regulation. Taking this possibility into consideration,
our finding of the Sp1-mediated mechanism, which provides a
platform the injury-inducible transcription factors, stretches the
possibility of understanding global gene regulation during nerve
regeneration.
POTENTIAL INVOLVEMENT OF EPIGENETIC MODIFICATION
Epigenetic modification of both histones and DNA is emerging
as a fundamental mechanism by which neurons adapt their tran-
scriptional responses to environmental cues (Jaenisch and Bird,
2003; Riccio, 2010). Histone modification including acetylation,
methylation, phosphorylation, ubiquitination, and sumoylation
modifies local chromatin structure or provides binding sites for
non-DNA-binding chromatin proteins. The combination of such
modifications can induce the formation of transiently closed or
open chromatin domains. Open chromatin is associated with
active gene expression, while closed chromatin is associated with
DNA compaction and gene repression.
Chromatin-modifying enzymes are found in large multipro-
tein complexes that are recruited to gene promoters by the
transcription factors that bind to specific DNA sequences and
confer target specificity (Borrelli et al., 2008). In neurons, HATs
and HDACs are the best-characterized chromatin-modifying
enzymes. Multiple lines of evidence suggesting that epigenetic
regulation is involved in neurodegenerative pathology (Julii et al.,
2010; Ma et al., 2010), and that the use of HDAC inhibitors com-
bats neurodegenerative conditions in cellular and disease models
(Chuang et al., 2009), have been accumulated. In this context, it
is conceivable that epigenetic regulation by chromatin modifiers
influences nerve regeneration (Figure 3). Indeed, nerve injuries
such as optic nerve injury and hypoglossal nerve injury enhance
the expression of HDAC family proteins (Pelzel et al., 2010) and
our unpublished data. Neuron-restrictive silencer factor (NRSF)
is up-regulated after sciatic nerve injury and recruits HDACs to
suppress the expression of Nav1.8 sodium channels, u-opioid
receptor (MOP) and the voltage-gated potassium channel Kv4.3
in injured DRG neurons (Uchida et al., 2010a,b). Usually, NRSF
represses the expression of neuronal genes in non-neuronal cells,
although it can be an activator in some situations (Ballas et al.,
2005). This suggests that the normal pattern of gene expression
in neurons can be reversed in injured neurons to allow expres-
sion of non-neuronal genes as observed in the genes encoding
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FIGURE 3 | The possible involvement of epigenetic modification during
nerve regeneration. In addition to the involvement of numerous
transcriptional factors shown in Figure 1, the epigenetic modification of
chromatin structure might affect the gene expression following nerve injury.
Both histone modification including acetylation and phosphorylation and
DNA modification such as methylation are associated with active gene
expression as well as gene repression. Furthermore, microRNAs are
implicated as potent silencers of gene expression.
ERK and Shc (Kiryu et al., 1995a; Tanabe et al., 1998). Another
point is that HATs and HDACs participate in the activities of
numerous transcription factors, such as p53, Sp1, Smad1, CREB
NFκB, and STAT, which are also associated with nerve regenera-
tion. Recently, Chen et al. and Jacob et al. reported the epigenetic
regulation of Schwann cells, showing that HDACs are essential
not only for chromatin condensation but also for the transcrip-
tional activation events that regulate survival and myelination.
HDACs have synergy with Sox10 and NFκB to activate myelin
genes via a spatiotemporally controlled transcriptional cascade
(Jessen and Mirsky, 2005; Chen et al., 2011; Jacob et al., 2011). It
is implied that a similar mechanism works in Schwann cells as
well as in neurons after nerve injury.
DNAmethylation at CpG dinucleotides in the genome is also a
major epigenetic mechanism, and is associated with a condensed
structure and transcriptional repression. DNAmethylation status
seems to be flexible rather than fixed to allow adaptation to envi-
ronmental changes. Damaged cells are no longer able to main-
tain their prior level of DNA methylation (Ramchandani et al.,
1999; Endres et al., 2000). Using the conditioning lesion model,
which enables lesioned dorsal column axons to undergo lengthy
regeneration in a segment of peripheral nerve transplanted into
spinal cord (Hoffman, 2010), Iskandar et al. reported that the
injury suppresses DNA methyltransferase (Dnmt) protein levels
in spinal cord and that DNA methylation is decreased globally
(Iskandar et al., 2010). The administration of folic acid, which
is required for DNA methylation through the folate pathway,
restored Dnmt protein expression as well as axonal regeneration.
Although it is not apparent which cells are responsible for this
effect, these findings imply that DNA methylation is a critical
factor for gene regulation after nerve injury.
Recently, a new player has emerged as a key molecule in
the epigenetic gene regulation of many biological processes.
microRNAs (miRNAs) act as potent silencers of gene expres-
sion via translational repression and/or mRNA destabilization.
Interestingly, some miRNAs are especially abundant in the ner-
vous system, suggesting that they might be particularly important
there. Exciting work has been reported in the fields of neu-
rogenesis, plasticity, and neurodegeneration (Eacker et al., 2009;
Siegel et al., 2011). Although the involvement of miRNAs in nerve
regeneration is not clear, the altered expression of some miRNAs
has been validated in DRG neurons after sciatic nerve injury
(Zhang et al., 2011a; Zhou et al., 2011). A recent elegant study
demonstrated that miRNA 206 in muscle promotes regeneration
of neuromuscular synapses (Williams et al., 2009). Gaining fur-
ther understanding of the roles of epigenetic modification and
miRNAs in nerve regeneration is the next critical step and will
advance our understanding of the gene regulation mechanisms
operative in injured neurons.
CONCLUSIONS
The challenging goal is to reach a sufficient understanding of
the global transcriptional machinery in injured neurons to real-
ize robust CNS regeneration. Accumulating evidence supports
the possibility that injury-inducible transcription factors like c-
Jun, ATF3, and STAT3 are involved in the intrinsic regenerative
growth ability in vivo. To achieve orchestrated expression of dis-
tinct RAGs, the transcriptional network and the multiprotein
complex could function in damaged neurons in response to envi-
ronmental cues. The Sp1 transcriptional machinery described in
this review provides one explanation for how numerous RAGs are
regulated simultaneously in injured neurons. Additionally, epige-
netic regulation is also emerging as a crucial factor in controlling
gene regulation during nerve regeneration. We are still far from a
comprehensive understanding of how the interplay of transcrip-
tional and epigenetic processes contributes to nerve regeneration.
It will be challenging to define the exact mechanism underlying
global transcriptional regulation in the nuclei of injured neurons.
As a biological tool that is currently available for studying
nerve regeneration in vivo, knockout mice have proven to be
very valuable (Zheng et al., 2006). However, for technical reasons,
only a few knockout mice for the transcription factors described
here have been studied using this method to date. Most tran-
scription factors are critical in development and normal cellular
function, so their knockout in mice would be lethal during devel-
opment and/or the development of mice would be influenced
by their ablation. The best approach is to perform gene dele-
tions specifically in injured neurons using Cre/loxP technology.
For this purpose, transgenic mice with Cre recombinase expressed
only in injured neurons appear to be a suitable approach.
Ongoing work using this approach will improve our under-
standing of how nuclear events activate the intrinsic ability to
drive axonal growth and will provide clues to specific therapeutic
strategies.
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